… This review discusses some of these novel immunomodulatory agents and evaluates their
potential use as … Approximately 250 000 cases of sepsis lead to fatalities in the USA annually [ …

… immunomodulatory agents described have a less severe SARS-CoV-2 infection, as they are
deemed some protection from their immunomodulatory … infection or death in this case series. …

… immunomodulating agents, including neutralizing monoclonal antibodies, corticosteroids,
and other molecules in the management of severe … corticosteroids in severe cases of COVID-…

… These cases are often diagnosed weeks after SARS-CoV-2 infection, and treatment includes
intravenous immunoglobulin and other immunomodulating agents such as steroids and …

… (four cases), three patients discontinued therapy after 8 – 18 months due to severe neuropathy.
… Forty-four cases received single-agent thalidomide at an initial dose of 200 mg/day with …

… value of the immunomodulatory agents for the management of the COVID-19 patients. …
In severe cases, both the regulatory T cells and DC enhanced post-transplantation. 4- The …

… Severe cases of human influenza … immunomodulatory agents for the treatment of severe
influenza that target dysregulated host inflammatory responses. If use of an immunomodulatory …

… to immunosuppressive and immunomodulatory therapies in case of rare skin diseases. …
immediately in case an infection develops as their immunomodulatory effects are also temporary. …

… ) with an immunomodulatory agent that suppresses immune … them might be their
immunomodulatory effects; these effects … -steroidal anti-inflammatory agents and glitazones are …

… case-by-case basis with input from appropriate specialty services. When available, the panel
strongly favors immunomodulatory agent … regarding immunomodulatory therapy for severe …